- The U.K.’s Royal College of General Practitioners (RCGP) accepted undisclosed payments from Pfizer while advocating for COVID-19 vaccines for children, raising questions about the integrity of their decision-making process.
- The RCGP’s failure to disclose financial ties to Pfizer is part of a broader pattern of conflicts of interest in public health institutions during the pandemic, eroding public trust in science and medicine.
- The decision to vaccinate children against COVID-19 has been described as “one of—if not the—single most ethically contentious decisions of the entire pandemic,” with potential long-term consequences for those involved.
- Major medical journals have received over $1 billion in payments from pharmaceutical companies between 2020 and 2022, casting doubt on the objectivity of published research and exacerbating concerns about financial conflicts of interest.
- Rebuilding trust in public health institutions requires greater transparency and accountability in the relationship between medical organizations and the pharmaceutical industry to ensure that profit does not take precedence over the well-being of the public.
The COVID-19 pandemic was a time of unprecedented uncertainty, fear and loss. Families around the world clung to the hope that science and public health institutions would guide them safely through the crisis. Yet, as revelations about financial conflicts of interest emerge, it becomes painfully clear that trust in these institutions may have been misplaced. The recent disclosure that the U.K.’s Royal College of General Practitioners (RCGP) failed to declare payments from Pfizer while advocating for COVID-19 vaccines for children is a stark reminder of the human cost of these ethical lapses.
A breach of trust
The RCGP, representing over 53,000 general practitioners, accepted more than £100,000 from Pfizer in 2021—more than double the amount received in 2020. These payments, categorized as “donations and grants” and “benefits in kind,” were not disclosed during critical meetings where the RCGP advocated for vaccinating children aged 12-15. This omission is particularly troubling given the Joint Committee on Vaccination and Immunisation (JCVI) had already determined that the benefits of vaccination for this age group were only “marginally greater than the potential known harms.”
Despite this, the RCGP’s then-chair, Dr. Martin Marshall, argued in favor of vaccinating children, citing a “strong consensus” among doctors and concerns about exacerbating inequalities. Yet, he failed to disclose the financial ties between the RCGP and Pfizer, the sole vaccine manufacturer authorized for children at the time. This lack of transparency raises serious questions about the integrity of the decision-making process and the motivations behind the push to vaccinate children.
For parents who trusted these institutions, the revelation is a bitter pill to swallow. Many families made difficult decisions based on the advice of medical professionals, believing it was in the best interest of their children. Now, they are left wondering whether those decisions were influenced by financial incentives rather than sound science. […]
— Read More: www.naturalnews.com
At Last, a Company With Integrity in the Gold IRA Industry
For several years, I’ve been vetting out precious metals companies in search of the best. I believe in gold and silver but it’s hard to find integrity in the Gold IRA industry. The vast majority operate with shady tactics and gigantic spreads that take advantage of Americans who simply want to protect their life’s savings.
I’ve found a handful that I like and I’ve worked with some of them. By no means would I “unrecommend” them because, again, I vetted them out and found them to be above the fold. Unfortunately, it isn’t hard to be better than the rest when the rest are so darn awful.
After years of searching, I finally found a company that truly operates with integrity. Augusta Precious Metals has three important attributes that set them far above the competition:
- Non-Commissioned Sales Team: I cannot stress how important and unique this is. With just about every other company in the Gold IRA industry, the sales teams make commission from every account they open. This means they steer their clients toward the gold and silver products with the highest commission. With Augusta Precious Metals, the team is solely focused on putting the best gold and silver for their clients into their IRA. They get paid to serve the best interests of the Gold IRA client, NOT their own commission pay.
- Incredibly Low Fees: Most Americans would be shocked if they knew the spread other Gold IRA companies charge. Augusta charges just 5% versus up to 45% elsewhere.
- No Pressure, No Gimmicks: There’s an understanding among most in the Gold IRA industry that fear and pressure is the way to go. Augusta Precious Metals takes a sober approach when working with clients because they hold integrity in the highest possible regard. This is why they don’t offer gimmicks like “free” or “bonus” silver. It’s also why they do not apply pressure tactics to get quick sales. Their educational and transparent approach to doing business is exceedingly rare in the Gold IRA industry.
